ChemoCentryx Inc. (NASDAQ:CCXIU) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Klein Other companies: Churchill Capital Corp. XIII (See Remarks, Director · Since at least Jul 30, 2026); Churchill Capital Corp XII (See Remarks, Director · Since at least Apr 27, 2026); Agility Robotics, Inc. (See Remarks, Director · Since at least Dec 16, 2025); Infleqtion, Inc. (See Remarks, Director · Since at least May 13, 2025); Oklo Inc. (Board Member · Since at least Jul 7, 2021); Claritev Corporation (Director · Since at least Feb 13, 2020); Skillsoft Corp. (Director · Since at least Jun 26, 2019); Churchill Capital Corp VII (See Remarks, Director · Feb 11, 2021 – Feb 11, 2021 · Past); Churchill Capital VI Corp (See Remarks, Director · Feb 11, 2021 – Feb 11, 2021 · Past); Churchill Capital V Corp (See Remarks, Director · Dec 15, 2020 – Dec 15, 2020 · Past); Lucid Group, Inc. (See Remarks, Director · Jul 29, 2020 – Jul 29, 2020 · Past); Gordon Pointe Acquisition Corp (Director · Jul 1, 2020 – Jul 22, 2020 · Past); IHS Holding Limited (Director · Dec 1, 2008 – Apr 10, 2013 · Past); Citigroup, Inc. (Co-CEO Citi Markets & Banking · Feb 1, 2007 – Jan 22, 2008 · Past) | See Remarks, Director · Since at least Nov 2, 2026 |
| Geoffrey Parker Other companies: Allogene Therapeutics, Inc. (Executive Vice President · Since at least Oct 16, 2023); Perrigo Company plc (Director · Since at least Nov 7, 2016); Better Therapeutics, Inc. (Director · Oct 28, 2021 – Dec 18, 2023 · Past); Tricida Inc (COO, CFO and EVP · Jun 27, 2018 – Feb 28, 2022 · Past); Genomic Health Inc (Director · Jun 21, 2016 – Nov 8, 2019 · Past); Sunesis Pharmaceuticals Inc (Director · Mar 23, 2016 – May 31, 2017 · Past); Genoptix Inc (Director · Jun 1, 2010 – Feb 25, 2011 · Past) | Director · Feb 8, 2012 – Oct 20, 2022 · Past |
| David E. Wheadon Other companies: Indivior Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Supernus Pharmaceuticals, Inc. (Director · Since at least Jan 1, 2026); Vaxart, Inc. (Director · Since at least Aug 4, 2022); Sotera Health Company (Director · Since at least May 27, 2022); Karuna Therapeutics Inc (Director · Jun 15, 2022 – Mar 18, 2024 · Past) | Director · May 26, 2022 – Oct 20, 2022 · Past |
| Henry A McKinnell Other companies: Federal Street Acquisition Corp (Director · Jul 13, 2017 – Jan 4, 2019 · Past); Optimer Pharmaceuticals Inc (CEO and Chairman of the Board, Director · Jan 10, 2011 – Oct 24, 2013 · Past); Angiotech Pharmaceuticals Inc (Director · May 12, 2008 – Dec 10, 2009 · Past); Moody's Corporation (Director · Feb 8, 2006 – Mar 18, 2021 · Past); Exxon Mobil Corporation (Director · Dec 30, 2005 – May 30, 2007 · Past); Pfizer, Inc. (Director · Dec 30, 2005 – Feb 28, 2007 · Past) | Director · Oct 17, 2016 – May 20, 2022 · Past |
| James L. Tyree Other companies: Genelux Corporation (Lead Independent Director · Since at least Jan 25, 2023); Assertio Holdings, Inc. (Director · May 19, 2020 – Mar 14, 2024 · Past); Depomed Inc (Director · Oct 17, 2016 – May 8, 2018 · Past); Innoviva, Inc. (Director · Jun 2, 2014 – Apr 20, 2017 · Past); Abbott Laboratories (Executive Vice President · Feb 14, 2006 – Feb 27, 2009 · Past) | Director · Jun 5, 2012 – Oct 20, 2022 · Past |
| Rishi Gupta Other companies: Turnstone Biologics Corp. (Director · Since at least Jul 20, 2023); Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Feb 23, 2023); Verona Pharma plc (Director · Jan 1, 2021 – May 11, 2023 · Past); Dimension Therapeutics (Director · Oct 21, 2015 – May 19, 2016 · Past); Sientra Inc (Director · Oct 28, 2014 – Oct 28, 2014 · Past) | Director · Feb 8, 2012 – Jun 22, 2012 · Past |
| William C. Fairey Other companies: Ascendis Pharma A/S (Director · Since at least Mar 18, 2026); KalVista Pharmaceuticals, Inc. (Director · Since at least Apr 18, 2024); Rein Therapeutics, Inc. (Director · Since at least Oct 31, 2023); Mirum Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2021); MyoKardia Inc (EVP, Chief Commercial Officer · Jan 28, 2019 – Nov 17, 2020 · Past) | Chief Operating Officer · Jan 3, 2018 – Jan 3, 2018 · Past |
| Anne-Marie Duliege Other companies: Rigel Pharmaceuticals, Inc. (EVP & Chief Medical Officer · Mar 7, 2016 – Mar 20, 2019 · Past); Affymax Inc (Chief Medical Officer · Jan 1, 2008 – Jan 30, 2013 · Past) | EVP, Chief of Strategic Dev. · Mar 25, 2014 – Nov 18, 2014 · Past |
| Edward Penhoet Other companies: Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Scynexis, Inc. (Director · May 2, 2014 – Jun 4, 2015 · Past) | Director · Feb 8, 2012 – May 23, 2013 · Past |
| Joseph M Feczko Other companies: Keryx Biopharmaceuticals Inc (Director · Jul 16, 2010 – Jun 17, 2015 · Past); Pfizer, Inc. (Senior Vice President · Dec 30, 2005 – Mar 13, 2009 · Past) | Director · Apr 25, 2012 – Oct 20, 2022 · Past |
| Jennifer Lyn Herron Other companies: Ariad Pharmaceuticals Inc (Exec V.P. Chief Comm'l Officer · May 31, 2016 – Feb 16, 2017 · Past) | Director · Jun 28, 2022 – Oct 20, 2022 · Past |
| Juan Jaen Other companies: Arcus Biosciences, Inc. (President · Since at least Mar 14, 2018) | SVP, Drug Discovery & CSO · Feb 8, 2012 – Jul 23, 2013 · Past |
| Roger C Lucas Other companies: Bio-Techne Corp (Director · Feb 1, 2006 – Oct 10, 2017 · Past) | Director · Feb 8, 2012 – Mar 5, 2019 · Past |
| Thomas J Schall Other companies: Immuneering Corporation (Director · Since at least Mar 11, 2024) | President and CEO, Director · Feb 8, 2012 – Oct 20, 2022 · Past |
| Yi Ching Yau Other companies: BridgeBio Pharma, Inc. (Chief Accounting Officer · Oct 9, 2019 – Nov 16, 2020 · Past) | SVP, Finance & Acctg Officer · Jun 6, 2022 – Jun 7, 2022 · Past |
| Ira Klein | Director · May 23, 2013 – May 21, 2015 · Past |
| Israel Charo | SVP, Research · Sep 17, 2014 – Sep 18, 2014 · Past |
| Markus J Cappel | Chief Bus. Officer & Treasurer · Feb 8, 2012 – Oct 20, 2022 · Past |
| Pui San Kwan | Principal Acctg Officer · Mar 5, 2018 – Feb 25, 2021 · Past |
| Rajinder Singh | SVP, Research · Apr 15, 2019 – Apr 15, 2019 · Past |
| Susan M Kanaya | See Remarks, Director · Feb 8, 2012 – Oct 20, 2022 · Past |
| Tausif Butt | EVP, Chief Operating Officer · Feb 23, 2021 – Oct 20, 2022 · Past |
| Thomas A Edwards | Director · Jul 28, 2015 – Oct 20, 2022 · Past |